Trial Details
RecruitingBasic Information
| Clinical ID | c3109 |
|---|---|
| Identifier | NL-OMON20310 |
| Trial Title | Lengthening Adalimumab Dosing Interval in IBD patients in long term remission, the__LADI study. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn's Disease__Ulcerative Colitis__Inflammatory Bowel Disease__Adalimumab |
| Interventions | Intervention: adalimumab 40mg every 21 days Control: adalimumab 40mg every 14 days |
Participant Information
| Sponsor | Erasmus MC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |